Alan Tan

882 citations

52 papers · 442 indexed · h-index 11

Impact in

Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
Oncology
- CAR-T cell therapy research

Papers in ⓘ

Oncology 23
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 4
- Cutaneous Melanoma Detection and Management 3
Pulmonary and Respiratory Medicine 22
- Renal cell carcinoma treatment 10
- Prostate Cancer Treatment and Research 6

Co-authors: Marc B. Hershenson (6 shared papers)Limei Zhou (3 shared papers)Anning Lin (2 shared papers)Kristen Page (2 shared papers)Jing Li (1 shared paper)Huda Salman (2 shared papers)John M. Richart (1 shared paper)Jun Miyoshi (1 shared paper)
Journals: Journal of Clinical Oncology (25 papers)Pediatric Research (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Cancer Research (1 paper)International Journal of Surgery (1 paper)
Partner nations: United States Canada United Kingdom

In The Last Decade

Alan Tan

42 papers receiving 437 citations

Peers

Countries citing papers authored by Alan Tan

Since Specialization

Citations

This map shows the geographic impact of Alan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Tan more than expected).

Fields of papers citing papers by Alan Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Tan. The network helps show where Alan Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Tan Line = papers co-authored together Alan Tan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	German cockroach extract increases bronchial epithelial cell interleukin‐8 expression Clinical & Experimental Allergy ·Rajesh K. Bhat, Kristen Page, Alan Tan, Marc B. Hershenson	2003	58
2	Ras and Mitogen-Activated Protein Kinase Kinase Kinase-1 Coregulate Activator Protein-1– and Nuclear Factor-κB–Mediated Gene Expression in Airway Epithelial Cells American Journal of Respiratory Cell and Molecular Biology ·Limei Zhou, Alan Tan, Svetlana Iasvovskaia, Jing Li, Anning Lin, Marc B. Hershenson	2003	58
3	Signaling intermediates required for NF-κB activation and IL-8 expression in CF bronchial epithelial cells American Journal of Physiology-Lung Cellular and Molecular Physiology ·Jing Li, Xa Dwight Johnson, Svetlana Iazvovskaia, Alan Tan, Anning Lin, Marc B. Hershenson	2003	48
4	DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM). Journal of Clinical Oncology ·Ajay K. Nooka, Keith Stockerl‐Goldstein, Hang Quach, Adam Forbes, María‐Victoria Mateos, Amit Khot, Alan Tan, Rafat Abonour, Bikramjit Chopra, Rachel Rogers, Geraldine Ferron‐Brady, Jacqueline Davidge, Steve Frey, Anne Yeakey, Mala K. Talekar, Katarina Luptakova, Ira Gupta, Rakesh Popat	2020	32
5	Gut microbes and the liver circadian clock partition glucose and lipid metabolism Journal of Clinical Investigation ·Katya Frazier, Sumeed Manzoor, Katherine Carroll, Orlando DeLeon, Sawako Miyoshi, Jun Miyoshi, Marissa St. George, Alan Tan, Evan A. Chrisler, Mariko Izumo, Joseph S. Takahashi, Mrinalini C. Rao, Vanessa Leone, Eugene B. Chang	2023	30
6	Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells Respiratory Physiology & Neurobiology ·Limei Zhou, Alan Tan, Marc B. Hershenson	2004	19
7	Rhinovirus 16 3C Protease Induces Interleukin-8 and Granulocyte-Macrophage Colony-Stimulating Factor Expression in Human Bronchial Epithelial Cells Pediatric Research ·Ann W. Funkhouser, Jeong-Ah Kang, Alan Tan, Jing Li, Limei Zhou, Mark K. Abe, Julian Solway, Marc B. Hershenson	2003	19
8	Phase I Study Protocol: NKTR-255 as Monotherapy or Combined with Daratumumab or Rituximab in Hematologic Malignancies Future Oncology ·Nina Shah, Miguel‐Angel Perales, Cameron J. Turtle, Mitchell S. Cairo, Andrew J. Cowan, Hayder Saeed, Lihua E. Budde, Alan Tan, Zachary Lee, Kazuharu Kai, Mario Q. Marcondes, Jonathan Zalevsky, Mary Tagliaferri, Krina K. Patel	2021	17
9	Interleukin (IL)-1β in Tracheal Aspirates from Premature Infants Induces Airway Epithelial Cell IL-8 Expression via an NF-κB Dependent Pathway Pediatric Research ·Thomas K. Shimotake, Farzana M Izhar, Kandelaria M. Rumilla, Jing Li, Alan Tan, Kristen Page, Allan R. Brasier, Michael D. Schreiber, Marc B. Hershenson	2004	16
10	Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy Cancer Chemotherapy and Pharmacology ·Anilkumar Katta, Mark Fesler, Alan Tan, Giao Vuong, John M. Richart	2010	14
11	The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy Urologic Oncology Seminars and Original Investigations ·Kelsey Danley, Alan Tan, William J. Catàlona, Robin Leikin, Irene Helenowski, Borko Jovanovic, Michael Gurley, Timothy M. Kuzel	2021	12
12	Spontaneous Rupture of the Spleen in the Presentation of Acute Myeloid Leukemia Journal of Clinical Oncology ·Alan Tan, Mohammadbagher Ziari, Huda Salman, Wilman Ortega, Cherise Cortese	2007	10
13	MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001). Journal of Clinical Oncology ·Shilpa Gupta, Karla V. Ballman, Matt D. Galsky, Michael J. Morris, Ronald C. Chen, Timothy A. Chan, Laurent Dercle, Yujia Wen, Srikala S. Sridhar, Aihua Edward Yen, Petros Grivas, Alan Tan, Shiva Baghaie, Jonathan E. Rosenberg	2022	9
14	Combination treatment of bilateral periocular sebaceous carcinomas with microsatellite instability with neoadjuvant pembrolizumab and Mohs surgery Australasian Journal of Dermatology ·Alexander D. Woods, Solomiya Grushchak, Kenya M. Williams, Alan Tan, Aleksandar L. Krunic	2022	9
15	Phase 1a/b open-label study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally advanced or metastatic solid tumors and urothelial carcinoma. Journal of Clinical Oncology ·Meredith McKean, David H. Aggen, Nehal J. Lakhani, Babar Bashir, Jason J. Luke, Jean Hoffman‐Censits, Omar Alhalabi, I. Alex Bowman, Elizabeth A. Guancial, Alan Tan, Trupti Lingaraj, Marissa Timothy, Katherine Kacena, Karim Malek, Sergio Santillana	2022	8
16	Longitudinal detection of circulating tumor DNA in patients with advanced renal cell carcinoma. Journal of Clinical Oncology ·Arnab Basu, Revathi Kollipara, Sumedha Sudhaman, Tamara Mahmood, Natalia Pajak, Carcia Carson, Punashi Dutta, Mark Calhoun, Adam ElNaggar, Minetta C. Liu, James Ferguson, Charles C. Peyton, Soroush Rais‐Bahrami, Alan Tan	2023	8
17	SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer. Journal of Clinical Oncology ·Ulka N. Vaishampayan, Catherine M. Tangen, Abhishek Tripathi, Brian Shuch, Sumanta K. Pal, Pedro C. Barata, Alan Tan, Peggy Zuckerman, Edward Mayerson, Primo N. Lara, Neeraj Agarwal, Nicholas J. Vogelzang, Hyung Lae Kim, Ian M. Thompson	2022	7
18	212P A phase Ib/II study of palazestrant (OP-1250) in combination with ribociclib in patients with estrogen receptor-positive human epidermal growth factor receptor 2-negative (ER+, HER2-) metastatic breast cancer ESMO Open ·Virginia F. Borges, Joanne Chien, Sara Nunnery, Jason Mouabbi, C.X. Ma, Saraj Bahadur, Felipe Javier Chaves, Dorothy A. Potter, Dhanusha Sabanathan, Alan Tan, Lin Sun, Demiana Faltaos, Maya Tonda, Naiheng Lin	2024	6
19	Perioperative Use of ctDNA to Guide Treatment for Urothelial Carcinoma: The Future is Now. PubMed ·Tyler F. Stewart, Healther Chalfin, Nicholas I. Simon, Alan Tan, Andrea B. Apolo, Rana R. McKay	2024	5
20	Alliance A031902 (CASPAR): A randomized, phase (ph) 3 trial of enzalutamide with rucaparib/placebo as novel therapy in first-line metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Arpit Rao, Glenn Heller, Charles J. Ryan, David James VanderWeele, Lionel D. Lewis, Alan Tan, Colleen Watt, Ronald C. Chen, Manish Kohli, Pedro C. Barata, Benjamin A. Gartrell, Robert L. Grubb, Amylou C. Dueck, Yujia Wen, Michael J. Morris	2022	5

About Alan Tan

Alan Tan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 52 papers that have together received 442 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), Cancer Genomics and Diagnostics (12 papers), Renal cell carcinoma treatment (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Prostate Cancer Treatment and Research (6 papers), Genetic factors in colorectal cancer (4 papers), CAR-T cell therapy research (4 papers) and Cutaneous Melanoma Detection and Management (3 papers). The work is most often cited by research in Immunology and Allergy (42 citations), Oncology (118 citations), Cancer Research (64 citations), Hematology (43 citations) and Emergency Medical Services (27 citations). Alan Tan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc B. Hershenson, Limei Zhou, Anning Lin, Kristen Page, Jing Li, Jing Li, Huda Salman, John M. Richart, Jing Li and Jun Miyoshi. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Research, Urologic Oncology Seminars and Original Investigations, Cancer Research and International Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact